TIGIT blocking or deficiency in HBsAg transgenic mice leads to chronic hepatitis and fibrosis, along with the emergence of functional HBsAg-specific cytotoxic T lymphocytes (CTLs) (141), suggesting the breakdown of adaptive immunotolerance by TIGIT blockade or deficiency. The gene discussed is TIGIT; the disease is chronic hepatitis.